Sutro Biopharma, Inc.
NASDAQ:STRO
3.95 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| -106.793 | -119.204 | -105.538 | -32.128 | -55.744 | -35.317 | -19.688 | 1.702 |
| Depreciation & Amortization
| 6.816 | 5.69 | 4.844 | 4.297 | 4.777 | 4.539 | 4.99 | 5.662 |
| Deferred Income Tax
| 24.144 | 0 | 7.235 | -41.008 | -1.297 | -1.5 | 3.004 | 0.08 |
| Stock Based Compensation
| 24.908 | 26.304 | 23.241 | 11.917 | 10.312 | 2.872 | 1.391 | 0.968 |
| Change In Working Capital
| -34.375 | 104.405 | -17.62 | -11.486 | -23.264 | 42.606 | -26.903 | -21.663 |
| Accounts Receivables
| -28.956 | 5.341 | -6.895 | 0.739 | -3.809 | -0.865 | -1.047 | -0.171 |
| Inventory
| 0 | 0 | -4.545 | -0.058 | -1.255 | -1.669 | -0.354 | -0.389 |
| Accounts Payables
| 4.812 | -1.225 | 6.433 | -0.947 | 2.253 | 0.209 | -0.473 | 0.874 |
| Other Working Capital
| -10.231 | 100.289 | -12.613 | -11.22 | -20.453 | 44.931 | -25.029 | -21.977 |
| Other Non Cash Items
| -26.316 | -13.646 | 6.159 | 0.606 | 0.193 | -0.517 | 0.132 | 0.098 |
| Operating Cash Flow
| -111.616 | 3.549 | -81.679 | -67.802 | -65.023 | 12.683 | -37.074 | -13.153 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -4.315 | -7.858 | -15.323 | -7.129 | -3.481 | -1.557 | -3.316 | -4.394 |
| Acquisitions Net
| -0.391 | 28.739 | 0 | 0 | 47.65 | 0 | 0 | 0.016 |
| Purchases Of Investments
| -460.301 | -216.671 | -248.727 | -130.741 | -196.226 | -81.463 | -14.22 | -52.304 |
| Sales Maturities Of Investments
| 460.692 | 189.498 | 166.726 | 138.385 | 148.576 | 2.75 | 50.058 | 66.273 |
| Other Investing Activites
| 0.391 | -28.73 | 0.009 | 0.089 | -47.65 | 0.08 | 0.08 | 0.016 |
| Investing Cash Flow
| -3.924 | -35.022 | -97.315 | 0.604 | -51.131 | -80.19 | 32.602 | 9.591 |
| Financing Activities: | ||||||||
| Debt Repayment
| -12.5 | -9.375 | 0 | -10 | -5 | 0 | -14.83 | 0 |
| Common Stock Issued
| 14.336 | 56.27 | 4.25 | 251.415 | 0.18 | 84.436 | -0.191 | 0.184 |
| Common Stock Repurchased
| -0.49 | -0.463 | -0.007 | -0.314 | -0.297 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 150.544 | 1.881 | -0.987 | 28.146 | 0.933 | 86.349 | 14.639 | 0.177 |
| Financing Cash Flow
| 137.554 | 48.313 | 3.256 | 269.247 | -4.184 | 170.785 | 14.639 | 0.177 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 22.014 | 16.84 | -175.738 | 202.049 | -120.338 | 103.278 | 10.167 | -3.385 |
| Cash At End Of Period
| 69.268 | 48.126 | 31.286 | 207.024 | 4.975 | 125.313 | 22.035 | 11.868 |